Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

Bristol-Myers Squibb will pay $350 million to settle Hawaii's lawsuit over Plavix marketing practices, ending claims without ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

HPR's Ashley Mizuo reports on the settlement with pharmaceutical companies in the lawsuit over a blood thinner.

HONOLULU — Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general’s office ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

Hawaii will receive $700 million in a landmark settlement from pharmaceutical giants Bristol Myers Squibb and Sanofi ...

The settlement concludes a 12-year legal battle over the efficacy of Plavix for Asian, Pacific Islander and Native Hawaiian ...

The Department of Attorney General of Hawaii announced that Bristol-Myers Squibb (NYSE:BMY) and three units of Sanofi (NASDAQ ...

Hawaii had alleged the companies violated state consumer protection laws by marketing Plavix without disclosing that the drug could have a diminished or no effect for some people, particularly of ...